Patents by Inventor Richard William Ernest Clarkson

Richard William Ernest Clarkson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-BENZOYLAMINOBENZAMIDE DERIVATIVES AS BCL-3 INHIBITORS
    Publication number: 20220017478
    Abstract: The invention relates to a compound of general formula (I): wherein R1, R2, R3, R4, Q, m and n are as defined herein. The compounds are inhibitors of Bcl3 and are useful for the treatment of cancer, particularly metastatic cancer.
    Type: Application
    Filed: September 29, 2021
    Publication date: January 20, 2022
    Inventors: Andrew David Westwell, Andrea Brancale, Richard William Ernest Clarkson, Jitka Soukupova
  • 2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors
    Patent number: 11180466
    Abstract: The invention relates to a compound of general formula (I): wherein R1, R2, R3, R4, Q, m and n are as defined herein. The compounds are inhibitors of Bcl-3 and are useful for the treatment of cancer, particularly metastatic cancer.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: November 23, 2021
    Assignee: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
    Inventors: Andrew David Westwell, Andrea Brancale, Richard William Ernest Clarkson, Jitka Soukupova
  • 2-BENZOYLAMINOBENZAMIDE DERIVATIVES AS BCL-3 INHIBITORS
    Publication number: 20200031787
    Abstract: The invention relates to a compound of general formula (I): wherein R1, R2, R3, R4, Q, m and n are as defined herein. The compounds are inhibitors of Bcl-3 and are useful for the treatment of cancer, particularly metastatic cancer.
    Type: Application
    Filed: October 4, 2019
    Publication date: January 30, 2020
    Inventors: Andrew David Westwell, Andrea Brancale, Richard William Ernest Clarkson, Jitka Soukupova
  • 2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors
    Patent number: 10450285
    Abstract: The invention relates to a compound of general formula (I): wherein R1, R2, R3, R4, Q, m and n are as defined herein. The compounds are inhibitors of Bcl3 and are useful for the treatment of cancer, particularly metastatic cancer.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: October 22, 2019
    Assignee: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
    Inventors: Andrew David Westwell, Andrea Brancale, Richard William Ernest Clarkson, Jitka Soukupova
  • BCL-3 INHIBITORS
    Publication number: 20190248756
    Abstract: The present application relates to compounds of any one of Formulae I, Ia, Ib, Ic, Id, Ie, and If. Compounds of Formula I have the structure: wherein A, B, Y, Z, R2, R4, R5, R6, Rq and q are as defined herein. The compounds can be used as inhibitors of Bcl-3 and can be used for the treatment of cancer, particularly metastatic cancer.
    Type: Application
    Filed: April 29, 2019
    Publication date: August 15, 2019
    Inventors: Andrew David Westwell, Andrea Brancale, Richard William Ernest Clarkson
  • BCL-3 inhibitors
    Patent number: 10273218
    Abstract: The present application relates to compounds of any one of Formulae I, Ia, Ib, Ic, Id, Ie, and If. Compounds of Formula (I) have the structure: wherein A, B, W, Y, Z, R2, R4, R5, R6, Rq and q are as defined herein. The compounds can be used as inhibitors of Bcl-3 and can be used for the treatment of cancer, particularly metastatic cancer.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: April 30, 2019
    Assignee: University College Cardiff Consultants Limited
    Inventors: Andrew David Westwell, Andrea Brancale, Richard William Ernest Clarkson
  • BCL-3 INHIBITORS
    Publication number: 20170267653
    Abstract: The present application relates to compounds of any one of Formulae I, Ia, Ib, Ic, Id, Ie, and If. Compounds of Formula (I) have the structure: wherein A, B, W, Y, Z, R2, R4, R5, R6, Rq and q are as defined herein. The compounds can be used as inhibitors of Bcl-3 and can be used for the treatment of cancer, particularly metastatic cancer.
    Type: Application
    Filed: July 31, 2015
    Publication date: September 21, 2017
    Applicant: University College Cardiff Consultants Limited
    Inventors: Andrew David WESTWELL, Andrea BRANCALE, Richard William Ernest CLARKSON
  • 2-BENZOYLAMINOBENZAMIDE DERIVATIVES AS BCL-3 INHIBITORS
    Publication number: 20160185740
    Abstract: The invention relates to a compound of general formula (I): wherein R1, R2, R3, R4, Q, m and n are as defined herein. The compounds are inhibitors of Bcl3 and are useful for the treatment of cancer, particularly metastatic cancer.
    Type: Application
    Filed: July 31, 2014
    Publication date: June 30, 2016
    Inventors: Andrew David Westwell, Andrea Brancale, Richard William Ernest Clarkson, Jitka Soukupova